Pre-Market Highlights: Today’s Most Profitable Plays!

You are receiving this newsletter as a subscriber to Premium Stock Alerts

Hello Part-time Trader…👋

U.S. stock futures are on the rise in the premarket Friday, bouncing back after a rollercoaster trading session on Thursday. Investors are making bold moves, shifting away from technology stocks and exploring other opportunities.

The excitement is partly fueled by the prospect of interest-rate cuts from the Federal Reserve, which is giving a boost to select stocks. However, the big-name tech giants that once led the market rally are now feeling the heat and seeing a pullback. All eyes are on Friday's key inflation data—the personal consumption expenditures (PCE) index—which could be a game-changer for the market if it signals that the Fed has room to adjust rates.

In the bond market, yields are holding steady. The benchmark 10-year U.S. Treasury bond yield is at 4.258%, while the 2-year note yield stands at 4.437%. The market is buzzing with anticipation as traders and investors brace for the day's developments.

Happening Today

08:30 AM ET – Core PCE Price Index (MoM) (YoY) (Jun)

✓ 08:30 AM ET – Personal Spending (MoM) (Jun)

✓ 10:00 AM ET – Michigan 1-Year Inflation Expectations (Jul)

✓ 10:30 AM ET – Atlanta Fed GDPNow (Q3)

✓ 03:30 PM ET – CFTC Nasdaq 100 speculative net positions

Buffet, Bloomberg & 48 Congress Members Are Buying 1 Sector

Why are Warren Buffett, Jeff Bezos, Michael Bloomberg, "The Walmart Family", Bill Gates, and 48 members of Congress shifting their stocks in a frenzy?

And why are they all piling into ONE unique corner of the market...

The last time we saw the world's wealthiest investors move their cash into this corner of the market, Stocks exploded 2,020%, 5,609% Even as high as 8,437% in just ONE year. Now, it's all happening again.

Click here for the details.
Sponsored

PREMARKET SNAPSHOT📈

Market futures are up, with the S&P 500 rising by 0.72%, the Dow increasing by 0.56%, and the NASDAQ gaining 0.98%.

S&P500

$5480.25

⬆️ 0.72%

Dow

$40416.00

⬆️ 0.56%

NASDAQ

$19177.75

⬆️ 0.98%

SECTOR SNAPSHOT

The market showed a mixed performance with notable gains in Energy and Industrials, indicating some strength in these sectors. Financials and Materials also posted modest increases. However, Information Technology and Communication Services faced significant declines, dragging the overall sentiment. Consumer Discretionary and Real Estate also experienced minor setbacks, while Utilities and Health Care saw modest declines, reflecting a cautious market environment.

NAME

PRICE

%CHANGE

Consumer Discretionary

1,460.10

-0.42% 🔴

Consumer Staples

833.54

-0.03% 🔴

Energy

702.29

+1.47% 🟢

Financials

711.27

+0.28% 🟢

Health Care

1,736.11

-0.57% 🔴

Industrials

1,050.52

+0.76% 🟢

Materials

566.07

+0.26% 🟢

Real Estate

251.36

-0.57% 🔴

Information Technology

4,148.14

-1.14% 🔴

Communication Services

287.91

-1.86% 🔴

Utilities

357.95

-0.88% 🔴

Unique Tesla Strategy Turned $1,000 into $9,770 in 20 Trading Days

Hundreds of new traders have adopted this unique new way to trade Tesla shares. In 2024 it's shown opportunities to collect substantial gains in as little as 6 days. The next trade is scheduled for this Thursday.

Click here for details
Sponsored

PreMarket Unusual Volume Stocks

📈 Carbon Revolution Public Ltd. Co. (CREV): Carbon Revolution Public Ltd. Co. experienced a significant increase in trading activity with a volume of 2,547,754, far exceeding its average volume of 16,160. This surge in activity led to a 91.25% price change, reflecting heightened market interest.

📈 Windtree Therapeutics Inc (WINT): Windtree Therapeutics Inc saw an extraordinary surge in volume, trading 4,528,165 shares compared to its average of 61,470. This dramatic increase resulted in a 105.17% price change, indicating strong investor activity.

📈 Avinger Inc (AVGR): Avinger Inc's trading volume soared to 648,797, significantly higher than its average of 18,540. Despite the increased trading activity, the stock experienced a -14.29% price change.

📈 BurgerFi International Inc (BFI): BurgerFi International Inc saw its volume rise to 10,789,043, far surpassing its average of 580,810. This massive uptick in trading activity resulted in a significant 66.92% price change.

📈 Vintage Wine Estates Inc (VWE): Vintage Wine Estates Inc's volume spiked to 13,430,896, a substantial increase from its average of 1,679,830. The stock's 20.03% price change highlights the impact of the increased trading activity.

40 Years Of Investing Secrets - 1 Free Guide

Investing expert Tom Busby's free guide, the Little Black Book, could do two things:

First, empower everyday traders to make what could be more profitable choices and second...

It could make the execs on Wall Street absolutely furious.

Find out why today!

Click here to get your free copy of Busby's Little Black Book, now!
Sponsored

Premarket Picks

BurgerFi International (BFI) stock soared over 72% in pre-market trading, reaching $0.37 per share. The surge follows the company's announcement of a settlement agreement with Lion Point Capital.

Coursera (COUR) shares jumped 26% in pre-market trading, surpassing $9.35 per share. The increase comes after the company reported strong second-quarter 2024 financial results.

Carbon Revolution (CREV) stock climbed more than 112% in pre-market trading, exceeding $13.13 per share. The company announced it will supply carbon fiber wheels for the new Chevrolet Corvette ZR1.

Everi Holdings (EVRI) shares rose over 36% in pre-market trading, hitting $12.50 per share. The company will be acquired by a new holding company owned by Apollo Global Management in a $6.3 billion all-cash deal.

Below is a list of other hot stocks in pre-market today:

Pre Market Gainers

Pre Market Change

Pre Market Volume

SLNA

+21.28%

55.50M

BFI

+88.64%

8.59M

ZPTA

+23.15%

2.59M

VWE

+14.31%

2.07M

WINT

+126.14%

1.80M

RR

+11.50%

1.45M

SERV

+9.07%

1.03M

CREV

+62.07%

425.22K

SPEC

+4.35%

273.23K

MARA

+5.57%

208.00K

Experts Say: Buy TSLA Each Thursday Afternoon

A new study says Thursday afternoon is the best day to trade Tesla shares. In 2023 it's shown opportunities to collect gains 100% or more in six days or less.

The next Tesla Trade could be posted this Thursday afternoon.

Join for details

Click here for details
Sponsored

Important FDA

Recently Announced

Phathom Pharmaceuticals (PHAT) received positive news on July 18th, 2024, when the FDA approved its VOQUEZNA tablets for treating adult heartburn caused by non-erosive GERD.

Arcutis Biotherapeutics (ARQT) also celebrated a victory on July 9th, 2024, with the FDA's approval of Roflumilast Cream 0.15%. This topical treatment offers a new approach to managing mild to moderate atopic dermatitis (eczema) in adults and children as young as six, expanding treatment options for this chronic condition.

Unfortunately, Rocket Pharmaceuticals (RCKT) faced a setback on June 28th, 2024. The FDA issued a Complete Response Letter (CRL) for KRESLADI (RP-L201), a potential treatment for Leukocyte Adhesion Deficiency-I. The CRL indicates that the FDA requires additional information or modifications before approving the drug.

Invest Early in AI: Transforming the $786B Media Landscape!

Seize this rare Reg A+ opportunity to invest early in a groundbreaking media company leveraging advanced AI to revolutionize the $786.2 billion digital marketing industry. This strategic growth approach integrates top-tier agencies, enhancing performance and driving rapid market expansion. Don't miss your chance to be part of this AI-driven transformation and secure high returns.

Don't wait-seize this groundbreaking investment opportunity now!
Sponsored

Upcoming Announcements

Several pharmaceutical companies have crucial FDA events scheduled for August.

scPharmaceuticals Inc. (SCPH) is awaiting an FDA decision on expanding the indication for its drug FUROSCIX to include New York Heart Association Class IV heart failure patients. A positive outcome could significantly impact the company's market reach.

ZEVRA THERAPEUTICS, INC. (ZVRA) is set for an FDA panel review on August 2nd to discuss its drug Arimoclomol as a potential treatment for Niemann-Pick disease type C. A favorable outcome from this panel could be a game-changer for the company. 

Adaptimmune Therapeutics plc (ADAP) is anticipating an FDA decision on August 4th regarding the use of Afami-cel for treating advanced synovial sarcoma. A positive verdict would mark a significant advancement in the treatment of this condition.

Lastly, Humacyte, Inc. (HUMA) is awaiting an FDA decision on August 10th on its Human Acellular Vessel for the treatment of vascular trauma. The outcome of this review will determine the product's path to market and its potential impact on patient care.

Happy investing,

Maeve Grace
Editor In Chief
Premium Trade Alerts

Important: This newsletter does not provide investment advice. The stocks mentioned should not be taken as recommendations. Your investments are solely your decisions.

Disclosure: I hold no positions in any companies mentioned, either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I have no business relationship with any company whose stock is mentioned in this article.

Reply

or to participate.